(Q54519817)

30 May 2018

title

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. (English)

1 reference

30 May 2018

author

Giuseppe Curigliano

4

1 reference

30 May 2018

author name string

Elisabetta Munzone

1

1 reference

30 May 2018

E Botteri

2

1 reference

30 May 2018

A Sciandivasci

3

1 reference

30 May 2018

F Nolè

5

1 reference

30 May 2018

M Mastropasqua

6

1 reference

30 May 2018

N Rotmensz

7

1 reference

30 May 2018

M Colleoni

8

1 reference

30 May 2018

A Esposito

9

1 reference

30 May 2018

L Adamoli

10

1 reference

30 May 2018

A Luini

11

1 reference

30 May 2018

A Goldhirsch

12

1 reference

30 May 2018

G Viale

13

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 April 2012

1 reference

30 May 2018

Breast Cancer Research and Treatment

published in

1 reference

30 May 2018

volume

134

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

277-282

1 reference

30 May 2018

Triple-negative breast cancer--current status and future directions

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Triple-negative breast cancer: an unmet medical need

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Stratifying triple-negative breast cancer: which definition(s) to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Proliferation marker Ki-67 in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Flexible regression models with cubic splines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Clinical significance of basal-like subtype in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

CMF revisited in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Is gene array testing to be considered routine now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2040-6

10.1007/S10549-012-2040-6

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018